This video captures Dr. Stem meeting the CEO of Exocobio, a company valued at 100 billion Korean Won. Exocobio is a successful company projected to achieve 51.8 billion Korean Won in sales in 2024, and it was the first to commercialize stem cell-derived exosome skin boosters. Exosomes are tiny vesicles containing intercellular signaling substances, known as skin boosters that show excellent effects in skin regeneration, anti-inflammation, and improving pores and scars. While it's true that stem cells produce exosomes, each exosome company possesses its unique know-how for extracting them. Dr. Stem expresses surprise upon meeting the CEO directly at the exhibition.
On Clinic | Last reviewed 2026-05-23